| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |